Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole D. Armstrong, James A. McCubrey, Roberta Maestro et al.|Oncotarget|2014Cited by 246
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancerJames A. McCubrey, Alberto M. Martelli, Dariusz Rakus et al.|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2016Cited by 151
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A. McCubrey, Massimo Libra, Timothy L. Fitzgerald et al.|Oncotarget|2016Cited by 110
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S. Steelman, James A. McCubrey, Timothy L. Fitzgerald et al.|Current Pharmaceutical Design|2016Cited by 45